Literature DB >> 10718034

Beyond survey data: a claims-based analysis of drug use and spending by the elderly.

E P Steinberg1, B Gutierrez, A Momani, J A Boscarino, P Neuman, P Deverka.   

Abstract

Previous estimates of Medicare beneficiaries total and out-of-pocket spending on outpatient prescription drugs have largely been based on data from the 1995 Medicare Current Beneficiary Survey and have focused on how expenditures vary among beneficiaries with different demographic characteristics. This paper reports the results of an analysis of prescription claims from 1998 for more than 375,000 elderly persons whose prescription benefit was managed by Merck-Medco Managed Care. In addition to examining how total and out-of-pocket drug spending in a well-insured population varies by age and sex, we report how total and condition-specific drug spending varies for elderly persons with ten common chronic diseases. Our results illustrate the highly skewed nature of prescription drug spending, even among those with drug coverage, and underscore the particularly high cost burden that pharmaceuticals place on elderly people with chronic diseases.

Entities:  

Mesh:

Year:  2000        PMID: 10718034     DOI: 10.1377/hlthaff.19.2.198

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  8 in total

1.  Drug expenditure trends in the Canadian provinces: magnitude and causes from 1998 to 2004.

Authors:  Steve Morgan
Journal:  Healthc Policy       Date:  2005-09

2.  Quantifying components of drug expenditure inflation: the British Columbia seniors' drug benefit plan.

Authors:  Steven G Morgan
Journal:  Health Serv Res       Date:  2002-10       Impact factor: 3.402

3.  Generic-only drug coverage in the Medicare Part D gap and effect on medication cost-cutting behaviors for patients with diabetes mellitus: the translating research into action for diabetes study.

Authors:  O Kenrik Duru; Carol M Mangione; John Hsu; W Neil Steers; Elaine Quiter; Norman Turk; Susan L Ettner; Julie A Schmittdiel; Chien-Wen Tseng
Journal:  J Am Geriatr Soc       Date:  2010-04-06       Impact factor: 5.562

Review 4.  Cost of pharmacological care of the elderly: implications for healthcare resources.

Authors:  Ciaran O'Neill; Carmel M Hughes; James Jamison; Anna Schweizer
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

5.  Prescription noncompliance due to cost among adults with disabilities in the United States.

Authors:  Jae Kennedy; Christopher Erb
Journal:  Am J Public Health       Date:  2002-07       Impact factor: 9.308

6.  Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program.

Authors:  William H Hernan; Michael Brandle; Ping Zhang; David F Williamson; Margaret J Matulik; Robert E Ratner; John M Lachin; Michael M Engelgau
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

7.  Prescription drug use in the elderly: a descriptive analysis.

Authors:  Elizabeth D Moxey; John P O'Connor; Karen D Novielli; Steven Teutsch; David B Nash
Journal:  Health Care Financ Rev       Date:  2003

8.  Factors influencing the variation in GMS prescribing expenditure in Ireland.

Authors:  A ConwayLenihan; S Ahern; S Moore; J Cronin; N Woods
Journal:  Health Econ Rev       Date:  2016-03-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.